InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Bogle Grant C., Director. Director active across 1 companies, notably Epizyme, Inc.. Aggregated, 6 filings have been logged. The latest transaction was filed on 2 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
087,500 shares0
Common Stock, par value $0.0001
SEC:0000899243-22-004828·
087,500 shares0
Common Stock, par value $0.0001
SEC:0000899243-22-004828:0·
087,500 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-033401·
087,500 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-033401:0·
08,060 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-023877·
08,060 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-023877:0·
6 of 6 declarations
About Bogle Grant C.
Grant C. Bogle is a Board Member at Epizyme, Inc. He plays a key role in the company's governance, bringing his expertise to guide strategic decisions. His experience in the biopharmaceutical sector allows him to contribute to innovation and operational efficiency within the company.
